PLK1酸化RhoGDI1并促进癌细胞迁移和入侵
Jeewon Lim1,2, Yo Sep Hwang1, Hyang Ran Yoon1
1Immunotherapy Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, 34141, Republic of Korea.
Cancer cell international
|February 14, 2024
概括
波罗样类激酶1 (PLK1) 酸化Rho瓜核酸解离抑制剂1 (RhoGDI1),通过RhoA激活促进癌细胞迁移和入侵. 这种相互作用为癌症进展提供了潜在的治疗点.
科学领域:
- 细胞生物学 细胞生物学
- 分子瘤学分子瘤学
- 生物化学 生物化学
背景情况:
- 罗氨酸核酸解离抑制剂1 (RhoGDI1) 调节罗基酶活性,对于移动等细胞过程至关重要.
- 在细胞迁移期间,RhoGDI1的酸化会影响Rho GTPase的激活.
研究的目的:
- 确定酸化RhoGDI1.1的新型激酶.
- 研究将RhoGDI1-PLK1相互作用与癌细胞迁移联系在一起的机制.
主要方法:
- 蛋白质相互作用测试 (免疫沉,GST下拉,PLA).
- 在体外激酶试验和RhoA激活试验.
- 细胞迁移和入侵试验 (Transwell),包括体内转移模型.
主要成果:
- 波罗样类激酶1 (PLK1) 与RhoGDI1.1直接相互作用.
- 在Thr7和Thr91处,PLK1酸化RhoGDI1,增强细胞运动性.
- 突变RhoGDI1 (aa 90-111) 抑制了PLK1相互作用,减弱了RhoA激活,并减少了癌细胞迁移,入侵和转移.
结论:
- 通过PLK1介导的RhoGDI1酸化,通过激活RhoA,促进癌细胞迁移和入侵.
- PLK1-RhoGDI1的相互作用与恶性进展有关,这表明了治疗潜力.
相关概念视频
Small GTPases - Ras and Rho
4.0K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
4.0K
Cell Polarization by Rho Proteins
2.7K
Cell polarity is the asymmetric distribution of cellular and membrane components, making one side of the cell different from the other. This polarity is essential to many processes such as embryogenesis, axon migration, glucose transport across epithelial cells, and directional cell migration. A migrating cell responds to intracellular or extracellular signals via molecular cascades that reorganize the actin cytoskeleton to establish this polarity. In these cells, the Rho family proteins Cdc42,...
2.7K
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K


